| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 541.37M | 435.63M | 521.02M | 363.88M | 337.40M | 544.22M |
| Gross Profit | 539.44M | 435.63M | 519.94M | 51.89M | 64.27M | 154.33M |
| EBITDA | 220.47M | 245.09M | 224.28M | 168.06M | 162.43M | 172.65M |
| Net Income | 91.19M | 95.34M | 83.55M | 32.27M | 70.35M | 61.06M |
Balance Sheet | ||||||
| Total Assets | 1.44B | 1.48B | 1.30B | 1.05B | 1.12B | 685.93M |
| Cash, Cash Equivalents and Short-Term Investments | 146.42M | 126.28M | 154.63M | 463.19M | 600.49M | 158.00M |
| Total Debt | 676.86M | 758.36M | 588.13M | 325.13M | 218.85M | 225.21M |
| Total Liabilities | 1.33B | 1.37B | 1.17B | 903.99M | 828.16M | 416.74M |
| Stockholders Equity | 114.73M | 112.79M | 128.84M | 145.58M | 291.43M | 269.19M |
Cash Flow | ||||||
| Free Cash Flow | -36.97M | -78.98M | -127.63M | 8.30M | 110.69M | 185.03M |
| Operating Cash Flow | -35.03M | -59.70M | -106.00M | 24.61M | 119.94M | 194.97M |
| Investing Cash Flow | -23.06M | -26.68M | -1.35M | -16.31M | -42.39M | -8.06M |
| Financing Cash Flow | 108.98M | 59.67M | 162.02M | -71.52M | -74.06M | -120.53M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | $1.22B | 14.74 | 31.30% | 5.51% | 11.64% | 18.08% | |
73 Outperform | AU$1.58B | 27.40 | 30.67% | 1.14% | 12.62% | 12.46% | |
68 Neutral | AU$34.30M | 15.56 | 7.05% | 5.20% | -7.29% | 60.64% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
61 Neutral | €1.20B | 12.60 | 79.56% | 8.65% | 7.99% | 14.07% | |
52 Neutral | AU$86.47M | -6.54 | -8.39% | ― | -6.45% | -364.91% | |
43 Neutral | AU$12.94M | -0.78 | ― | ― | 14.07% | -157.40% |
McMillan Shakespeare Limited announced a change in the director’s interest, specifically for Roberto De Luca, who has been issued 55,123 unquoted performance rights as part of an incentive-based remuneration under the Executive Incentive Plan. This issuance, approved by shareholders at the recent AGM, reflects the company’s commitment to aligning executive compensation with performance, potentially impacting its operational efficiency and stakeholder interests positively.
The most recent analyst rating on (AU:MMS) stock is a Buy with a A$21.50 price target. To see the full list of analyst forecasts on Mcmillan Shakespeare Limited stock, see the AU:MMS Stock Forecast page.
Mcmillan Shakespeare Limited has announced the issuance of 55,123 performance rights as part of an employee incentive scheme. These unquoted securities are intended to motivate and retain key personnel, potentially impacting the company’s operational efficiency and competitive positioning in the market.
The most recent analyst rating on (AU:MMS) stock is a Buy with a A$21.50 price target. To see the full list of analyst forecasts on Mcmillan Shakespeare Limited stock, see the AU:MMS Stock Forecast page.
McMillan Shakespeare Limited announced that its shareholders have approved an amendment to the company’s Constitution during the Annual General Meeting held on November 17, 2025. This change reflects the company’s commitment to maintaining robust governance practices and could potentially impact its operational framework, offering reassurance to stakeholders about its dedication to corporate governance.
The most recent analyst rating on (AU:MMS) stock is a Hold with a A$18.00 price target. To see the full list of analyst forecasts on Mcmillan Shakespeare Limited stock, see the AU:MMS Stock Forecast page.
McMillan Shakespeare Limited announced the results of its 2025 Annual General Meeting, where all resolutions were passed by a poll. The resolutions included amendments to the company’s constitution, renewal of takeover provisions, and re-election of directors, reflecting strong shareholder support and potentially strengthening the company’s governance and strategic direction.
The most recent analyst rating on (AU:MMS) stock is a Hold with a A$18.00 price target. To see the full list of analyst forecasts on Mcmillan Shakespeare Limited stock, see the AU:MMS Stock Forecast page.
McMillan Shakespeare Limited has announced the release of its 2025 Annual General Meeting Presentation, which is accessible to shareholders online. This announcement highlights the company’s commitment to transparency and engagement with its stakeholders, potentially impacting its market positioning positively by fostering trust and openness.
The most recent analyst rating on (AU:MMS) stock is a Hold with a A$18.00 price target. To see the full list of analyst forecasts on Mcmillan Shakespeare Limited stock, see the AU:MMS Stock Forecast page.
McMillan Shakespeare Limited’s recent annual general meeting highlighted the completion of their Simply Stronger program, which aims to enhance customer experiences and digital solutions for long-term growth. The company emphasized its commitment to sustainability and responsible business practices, which have contributed to improved customer outcomes, productivity gains, and sustained shareholder returns.
The most recent analyst rating on (AU:MMS) stock is a Hold with a A$18.00 price target. To see the full list of analyst forecasts on Mcmillan Shakespeare Limited stock, see the AU:MMS Stock Forecast page.
McMillan Shakespeare Limited has announced the appointment of Michelle Siekierka as the new Company Secretary, effective immediately. Siekierka, who joined the company in September 2025 as General Counsel, brings extensive experience in corporate and commercial law, as well as risk and compliance management, having previously worked with organizations such as Growthpoint Properties Australia and the Treasury Corporation of Victoria. Her appointment is expected to strengthen the company’s governance and compliance functions, enhancing its communication with the ASX and potentially impacting its operational efficiency and stakeholder relations.
The most recent analyst rating on (AU:MMS) stock is a Hold with a A$17.50 price target. To see the full list of analyst forecasts on Mcmillan Shakespeare Limited stock, see the AU:MMS Stock Forecast page.
McMillan Shakespeare Limited has announced its 2025 Annual General Meeting (AGM) will be held on 17 November 2025 as a hybrid event, allowing shareholders to participate either in person or online. This format aims to maximize accessibility for stakeholders. The AGM will include a review of the company’s performance for the financial year ended 30 June 2025, and shareholders will consider various resolutions as outlined in the meeting’s Notice and Explanatory Notes.
The most recent analyst rating on (AU:MMS) stock is a Hold with a A$17.50 price target. To see the full list of analyst forecasts on Mcmillan Shakespeare Limited stock, see the AU:MMS Stock Forecast page.